0
Last week, Rep. Stephen Lynch (D-MA) introduced a bill that would require OPM oversight of Pharmacy Benefits Managers when they negotiate with drug companies for federal employees. Currently, there is little oversight of this process.
Because of a lack of oversight, OPM cannot determine whether rebates from pharmaceutical companies are being passed on to the government or federal employees, and these rebates can be as high as 50%. HR 4489 also would prevent Pharmacy Benefits Managers from requiring federal employees to use less expensive prescription drug alternatives without their physicians’ approval.